September 15th, 2014
•We, based on knowledge from developmental biology and published research, developed an optimized protocol to efficiently generate A9 midbrain dopaminergic neurons from both human embryonic stem cells and human induced pluripotent stem cells, which would be useful for disease modeling and cell replacement therapy for Parkinson’s disease.
Videos relacionados
Generation of Neural Stem Cells from Discarded Human Fetal Cortical Tissue
Efficient Derivation of Human Neuronal Progenitors and Neurons from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
The Specification of Telencephalic Glutamatergic Neurons from Human Pluripotent Stem Cells
A cGMP-applicable Expansion Method for Aggregates of Human Neural Stem and Progenitor Cells Derived From Pluripotent Stem Cells or Fetal Brain Tissue
Feeder-free Derivation of Neural Crest Progenitor Cells from Human Pluripotent Stem Cells
Post-differentiation Replating of Human Pluripotent Stem Cell-derived Neurons for High-content Screening of Neuritogenesis and Synapse Maturation
Neuronal Differentiation from Mouse Embryonic Stem Cells In vitro
Derivation, Expansion, Cryopreservation and Characterization of Brain Microvascular Endothelial Cells from Human Induced Pluripotent Stem Cells
Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
Quantifying Levels of Dopaminergic Neuron Morphological Alteration and Degeneration in Caenorhabditis elegans
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados